Sinefungin (Adenosyl-Ornithine, Antibiotic 32232RP, A-9145) is a 5′-aminoalkyl analog of SAH and a natural product from cultures of Streptomyces incamatus and S. griseolus, acting as a novel and potent inhibitor of histone G9a and DNA methyltransferase.

MM-102 (also known as HMTase Inhibitor IX) is a novel and potent peptidomimetic inhibitor of MLL1 (Mixed lineage leukemia 1) with anticancer activity.

MS049 (MS-049; MS 049) 2HCl, the dihydrochloride salt of MS-049, is a potent and selective PRMT4 and PRMT6 inhibitor with potential anticancer activity.

C-7280948 (C7280948) is a selective PRMT1 (protein arginine methyltransferase) inhibitor with anticancer activity.

EPZ020411 (EPZ-020411) is a selective PRMT6 (protein arginine methyltransferase) inhibitor with antitumor effects.

GSK503 (GSK-503) is a novel, potent and specific inhibitor of Enhancer of zeste homolog 2 (EZH2) methyltransferase inhibitor with potential antitumor activity.

UNC0224 (UNC-0224) is a novel, potent and selective G9a histone methyltransferase inhibitor with anticancer activity.

Pinometostat (formerly EPZ 5676) is a potent and SAM (S-adenosyl methionine) competitive DOT1L protein methyltransferase (PMT) inhibitor with potential antitumor activity.

MI-3 (Menin-MLL Inhibitor 3) is a novel and potent inhibitor of menin-MLL interaction with potential antitumor activity.

BIX01294 is a novel and potent inhibitor of G9a histone methyltransferase with anticancer activity.